News, trends & global reports for pharma and biotech manufacturers, suppliers & scientists - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

News
The top business, scientific and regulatory news from the pharmaceutical and biotechnology industries.

AMAG Acquires Lumara Health for Over $1 Billion

September 30, 2014

AMAG Pharmaceuticals announced the acquisition of women?s health brand, Lumara Health, for $675 million, with an additional contingency of up to $350 million.

Baxter International Plans to Open R&D Center for Baxalta

September 30, 2014

Baxter International announced it will form a R&D center in Cambridge, Massachusetts for its new biopharmaceutical company, Baxalta.

NIH Seeks to Improve Vaccine Response with New Adjuvants

September 30, 2014

NIH seeks new therapeutic products to bolster the protective properties of vaccines.

New Report Details Players and Pipelines in the Biosimilar Space

September 30, 2014

A new Thomson Reuters BioWorld report outlines the more than 700 biosimilars that are currently in development and the emerging business opportunities that exist in the biopharmaceutical space.

Johnson & Johnson Acquires Alios BioPharma for $1.75 Billion

September 30, 2014

Johnson & Johnson announced the acquisition of Alios BioPharma to expand their portfolio of therapeutics for viral infections.

Ebola Outbreak Sparks EMA Review of Experimental Ebola Treatments

September 26, 2014

In response to the Ebola outbreak, EMA has started reviewing Ebola treatments in the development pipeline.

FDA and NIH Win Award for IP Licensing of Meningitis Vaccine

September 26, 2014

Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.

ISO Standard 14001 Enters the DIS Stage

September 26, 2014

International Organization for Standardization's environmental management standard 14001 has entered the draft stage, allowing public commentary on revisions.

Highlights from the CHMP September Meeting

September 26, 2014

CHMP has recommended 15 new medicines for approval and three extensions of indication.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here